Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Journal of Viral Hepatitis|March 5, 2003
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patientsC Tural, D Fuster, J Tor, et al.Journal of Viral Hepatitis|March 29, 2014
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patientsM Nevot, C Boesecke, M Parera, et al.Journal of Medical Virology|July 14, 1998
Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmissionA Ibáñez, M Giménez-Barcons, A Tajahuerce, et al.AIDS (London, England)|September 1, 1996
Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/lL Ruiz, J Romeu, B Clotet, et al.HIV Medicine|November 20, 2013
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baselineR Sanmartín, J Tor, A Sanvisens, et al.Journal of Viral Hepatitis|February 14, 2009
Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infectionS Moreno, J García-Samaniego, A Moreno, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2000
Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIVF Puig-Basagoiti, M Cabana, M Guilera, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic responseR Paredes, T Puig, A Arnó, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 21, 2007
Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studiesV González, E Martró, C Folch, et al.AIDS (London, England)|December 1, 1996
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddCL Ruiz, J Romeu, J Martínez-Picado, et al.Pageof 5